The models in which mGluR5 is elevated include multiple sclerosis (MS) [50], Alzheimer’s disease (AD) [80], amyotrophic lateral sclerosis (ALS) [81], epilepsy [82–85] and SCI [86–88]. Here, GRM5 is linked to myeloid sarcoma.